🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is designed to understand the blood concetration of PF-06412562 a...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2014-09
Trial ID
NCT02201511
Numerous psychiatric and neurodegenerative diseases like schizophrenia, dep...
Status
Completed
Location
University Hospital Zurich, Dept. of Clinical Pharmacology and Toxicology
Start Date
2017-05-08
Trial ID
NCT03181841
Treatments Being Tested
The purpose of this study is to test the safety and tolerability of the inv...
Status
Completed
Location
Penn State Milton S. Hershey Medical Center
Start Date
2018-09-24
Trial ID
NCT03665454
Treatments Being Tested
This study is designed to investigate the safety, tolerability pharmacokine...
Status
Completed
Location
Arcadia MRI & Imaging Center
Start Date
2015-04
Trial ID
NCT02418819
Treatments Being Tested
This study is designed to evaluate the safety and plasma concentrations of ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-11
Trial ID
NCT01959594
Treatments Being Tested
To assess the D1 receptor occupancy (D1 RO) in striatum after a single oral...
Status
Completed
Location
Invicro
Start Date
2018-09-10
Trial ID
NCT03686501
Treatments Being Tested
This study will evaluate D1 Receptor Occupancy (RO) following a single dose...
Status
Completed
Location
Karolinska Trial Alliance (KTA) M62
Start Date
2014-09
Trial ID
NCT02124213
Treatments Being Tested
This study will determine the safety and tolerability of PF-06412562 given ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-08
Trial ID
NCT01914796
Treatments Being Tested
This study will test whether CVL-562 (PF-06412562), a dopamine 1 partial ag...
Status
Completed
Location
Yale University
Start Date
2021-03-02
Trial ID
NCT04457310
The B7441003 study will assess PF-06412562 for motor benefit in Parkinson's...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-03
Trial ID
NCT02006290
Treatments Being Tested